AMED or CHE: Which Is the Better Value Stock Right Now? [Yahoo! Finance]
Amedisys Inc (AMED)
Last amedisys inc earnings: 2/18 04:15 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.amedisys.com
Company Research
Source: Yahoo! Finance
Chemed (CHE). But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look. Everyone has their own methods for finding great value opportunities, but our model includes pairing an impressive grade in the Value category of our Style Scores system with a strong Zacks Rank. The Zacks Rank favors stocks with strong earnings estimate revision trends, and our Style Scores highlight companies with specific traits. Amedisys has a Zacks Rank of #2 (Buy), while Chemed has a Zacks Rank of #3 (Hold) right now. This means that AMED's earnings estimate revision activity has been more impressive, so investors should feel comfortable with its improving analyst outlook. But this is just one factor that value investors are interested in. Value investors also tend to look at a number of traditional, tried-and-true figures to help them find stocks that they believe are undervalued at their current share price levels. Our Value category gra
Show less
Read more
Impact Snapshot
Event Time:
AMED
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AMED alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMED alerts
High impacting Amedisys Inc news events
Weekly update
A roundup of the hottest topics
AMED
News
- UnitedHealth's Optum Defends Multi-Billion Dollar Amedisys Deal, Ensures Competitive Landscape [Yahoo! Finance]Yahoo! Finance
- DOJ Lawsuit Questions UnitedHealth's $3.3 Billion Amedisys Deal [Yahoo! Finance]Yahoo! Finance
- DOJ sues UnitedHealth amid $3.3 billion bid to buy home care giant Amedisys [Yahoo! Finance]Yahoo! Finance
- DOJ sues UnitedHealth amid $3.3 billion bid to buy home care giant Amedisys [CBS News]CBS News
- DOJ sues to block UnitedHealth Group's $3.3 billion purchase of Amedisys [CNBC]CNBC
AMED
Earnings
- 11/6/24 - Miss
AMED
Sec Filings
- 11/13/24 - Form 3
- 11/7/24 - Form 4
- 11/7/24 - Form 144
- AMED's page on the SEC website